Project Number 4UH3NS101856-02 Agency/Funding Organization NINDS Funding Year 2018 View Full Project Details for Discovery/Development of GABA-A ?5 Positive Allosteric Modulators for Treatment of MCI due to AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AGENEBIO, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-14-293: BPN: SMALL MOLECULE DRUG DISCOVERY AND DEVELOPMENT FOR DISORDERS OF THE NERVOUS SYSTEM (UH2/UH3) FY Overall Cost $651,678 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official HACHICHA, MOHAMED
